ALNYLAM PHARMACEUTICALS, INC.
Pharmaceutical Preparations · 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA 02142
官方登記資料
0位追蹤者
2002成立於
關於 ALNYLAM PHARMACEUTICALS, INC.
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.
Source: Wikipedia
產業Pharmaceutical Preparations
總部675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA 02142
成立時間2002
法律形式C Corporation
狀態營運中
專利2398 項專利
Mannan binding lectin serine peptidase 2 (MASP2) IRNA compositions and methods of use thereofUS12709751B2 · 2026
MODIFIED DOUBLE-STRANDED RNA AGENTSUS20260218177A1 · 2026
關鍵數據
法律資訊
| 法定名稱 | ALNYLAM PHARMACEUTICALS, INC. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1178670在 SEC EDGAR 上查看 ↗ |
| EIN | 77-0602661 |
| 產業代碼(SIC) | 2834 |
| 登記地址 | 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA 02142 |
| 狀態 | 營運中 |
來源: SEC EDGAR · 更新於 2026年10月15日
聯絡方式與連結
地點
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA 02142
這是你的公司嗎?
免費認領此頁面,即可新增標誌、產品、照片與職缺,並回覆評論。
認領此頁面